GILD
Gilead's second quarter revenue grew 10% to $7.8B, beating estimates, but reported a larger-than-expected loss on acquisition charges.
Gilead Sciences reported second quarter 2026 revenue of $7.8 billion, a 10% increase year-over-year, driven by strong performance in its core business....
